The coronary endothelium: a highly active metabolic barrier for adenosine.
about
Heterogeneity of nucleoside transport inhibitory sites in heart: a quantitative autoradiographical analysisTime-dependent effects of theophylline on myocardial reactive hyperaemias in the anaesthetized dog.Elevated interstitial adenosine concentrations do not activate the muscle reflex.It is time to ask what adenosine can do for cardioprotection.Reflex increase in blood pressure during the intracoronary administration of adenosine in man.Adenosine and nitric oxide in exercise-induced human skeletal muscle vasodilatation.Interstitial adenosine concentration during norepinephrine infusion in isolated guinea pig hearts.Capillary endothelial transport of uric acid in guinea pig heartAdenosine therapy: a new approach to chronic heart failure.Role of adenosine in the sympathetic activation produced by isometric exercise in humans.Adenosine and chronic ischemia of the lower limbs.A historical perspective on the discovery of adenyl purines.An analysis of the myocardial transcriptome in a mouse model of cardiac dysfunction with decreased cholinergic neurotransmission.Stimulation of human umbilical vein endothelial cell proliferation by A2-adenosine and beta 2-adrenoceptors.Intravenous adenosine protects the myocardium primarily by activation of a neurogenic pathway.Understanding myocardial ischemic preconditioning, and the implications for a role of adenosine catabolism.Vasoconstrictor and vasodilator effects of adenosine in the kidney.Methotrexate modulates the kinetics of adenosine in humans in vivo.Growth regulation of the vascular system: an emerging role for adenosine.Covalent binding of a selective agonist irreversibly activates guinea pig coronary artery A2 adenosine receptors.A2-purinoceptor-mediated relaxation in the guinea-pig coronary vasculature: a role for nitric oxide.Cardiac endothelial transport and metabolism of adenosine and inosineTranscapillary adenosine transport and interstitial adenosine concentration in guinea pig hearts.Compartmentalization of angiotensin II generation in the dog heart. Evidence for independent mechanisms in intravascular and interstitial spaces.Targeting adenosine receptors in the development of cardiovascular therapeutics.Focus on cardiac pericytes.Identification of adenosine receptor subtypes expressed in the human endothelial-like ECV304 cells.Purinogen is not an endogenous substrate used in endothelial cells during substrate deprivation.Evidence that A2 purinoceptors are involved in endothelium-dependent relaxation of the rat thoracic aorta.Adenosine receptors and nucleoside transport sites in cardiac cells.Simulated ischemia does not protect against efferent sympathetic denervation following acute myocardial infarction in canine hearts.The transmethylation pathway as a source for adenosine in the isolated guinea-pig heart.Age-related changes in carotid vascular responses to adenosine and nitric oxide in the rat: in vitro and in vivo studies.Effect of adenosine receptor blockade on pial arteriolar dilation during sciatic nerve stimulation.Pre-conditioning activates adenosine utilization in a cost-effective way during myocardial ischaemia.Sole activation of three luminal adenosine receptor subtypes in different parts of coronary vasculature.In vivo evidence against a role for adenosine in the exercise pressor reflex in humans.Activation of pulmonary C fibres by adenosine in anaesthetized rats: role of adenosine A1 receptors.Role of K(ATP)(+) channels and adenosine in the control of coronary blood flow during exercise.Adenosine is not responsible for local metabolic control of coronary blood flow in dogs during exercise.
P2860
Q28359660-85161D56-23B3-4B50-8544-5617B499330AQ30443953-F0714E45-8013-483E-A2E0-CF84D0806B16Q31833629-C799099D-D20F-4C84-AFC9-415E75DF9FD6Q33731467-E29DA500-D142-47B9-A514-4769494F2BEEQ33848488-1CC71C55-0BD3-40C8-B45F-2BCD601AFBC9Q33888518-D38CB334-68F3-475D-863E-7A252658F37EQ34017568-4CC434CE-25AF-4FDF-BD7D-CCEB35F69F4FQ34034786-584C306B-6ADB-479D-A564-29F8E3C219EEQ34075147-518C4052-B1EE-43C2-8478-E457B84C6B75Q34140427-A5837157-F983-41D2-A21D-E1C5ED2C5B3BQ34158939-509DA854-9765-4D71-A049-252FBD3D145CQ34170491-96740D4F-A34B-4D5E-96D2-7EE0620E6BCAQ34328505-87EA68CD-8968-49CD-9027-164CCAB12EEAQ34793383-C4393113-BFD3-4854-9F92-9812098A2C84Q35049019-6A686C32-55B1-40DB-8F96-990C4CE0540AQ35072009-5DB3F82A-A54C-40D4-BFD7-59ACC7A7C981Q35211309-A564BF84-C40C-4ED5-A147-2FCE7CD3F18AQ35636960-050447DD-7DAA-4ABD-B4EC-1164363D2427Q36193019-885B585B-1C41-4AAC-8F98-94E71FA9F413Q36219741-E0243803-D8A5-41C7-8A30-34DF39F95C05Q36329629-674E5C98-DC50-4931-BDEF-9D7B94210621Q36353368-D704992E-C574-4FB4-BDDD-3D2DE42F069DQ36822769-41C2B14E-4169-497B-A0E1-95313DDC61EAQ37369862-77C20733-90E7-4016-B182-F46583997543Q37990558-02898399-BE1B-4F14-8BFA-F99523283ADBQ38084912-DB847B6E-8171-4B2B-93F1-AB7EC27CE1DCQ40441841-484091FB-B737-472F-A3C9-5A439B588AA2Q41788509-A9FB441A-44F0-4993-AF03-DC3BF12EDBEBQ41881462-EF90BE84-FC1C-46BE-9563-171C7B8C84A4Q41909348-4C8B8E9C-786C-43F0-AFAB-27D2C6809560Q42504417-D514DE2D-FAEF-4CEF-90E0-C081B5B2DA88Q42858362-9F5BF2DD-B486-4DF6-9A36-B4995EFEC162Q43057925-D4A50BCA-9A27-4002-9868-6829BC0EBF75Q43773138-DCD86F3C-3CE0-4B47-A901-DC2A84C89DD9Q43782255-F44A5654-F2F4-4027-A3B9-1D2938612D79Q44185609-FE0E5C03-BCC2-4BA1-8EE2-9025F6112B3BQ46427755-45D5DEF1-07EE-41DA-95A6-B9C157CEF5D9Q51517531-19758E99-919D-426B-B719-06B10A87A3AAQ52075780-5E7EEDC7-B461-47A4-877F-B537A3E8BF96Q52082669-63FDADF9-7A53-4F4B-8018-7EEEB123C637
P2860
The coronary endothelium: a highly active metabolic barrier for adenosine.
description
1985 nî lūn-bûn
@nan
1985年の論文
@ja
1985年論文
@yue
1985年論文
@zh-hant
1985年論文
@zh-hk
1985年論文
@zh-mo
1985年論文
@zh-tw
1985年论文
@wuu
1985年论文
@zh
1985年论文
@zh-cn
name
The coronary endothelium: a highly active metabolic barrier for adenosine.
@en
type
label
The coronary endothelium: a highly active metabolic barrier for adenosine.
@en
prefLabel
The coronary endothelium: a highly active metabolic barrier for adenosine.
@en
P2093
P2860
P356
P1476
The coronary endothelium: a highly active metabolic barrier for adenosine.
@en
P2093
P2860
P2888
P304
P356
10.1007/BF01907915
P577
1985-09-01T00:00:00Z